Your Daily News Roundup
Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!
Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better handle the ongoing COVID-19 coronavirus pandemic.
We’re taking the opportunity each week to share some of those resources that may help people get through this challenging time with the help of partners and experts.
We will be sharing the most recent, most relevant behavior change content from Beyond Type 1, JDRF, and more!
Take a look!
This week, we’re focusing on legislation that has the potential to help keep our community safe until we’re all safe, and resources to help our community weigh and mitigate risks as they head back into society.
Here are some of the stories to keep an eye on this week.
Check out these articles:
- Nationwide research participation remains far too low for racial/ethnic minorities and other underrepresented groups. Read this important piece on Why Diversity is Important in Research.
- T1D Exchange to Present Ten Studies Focused on Quality Improvement, Population Health, and Real-World Evidence in Type 1 Diabetes at 80th American Diabetes Association Scientific Sessions.
- “You Don’t Know When the Sugar’s Going to Kick In” – T1D Exchange Research on Managing Diabetes During a Marathon.
- Moving the Needle on the High-Risk T1D Patient – Lessons and Perspectives from the T1D Exchange Quality Improvement Collaborative
- The decision of whether to stay or leave a job that is not providing accommodations you need is a complicated and emotional one, especially during a pandemic. Check out this piece on fighting off job discrimination with Type 1 diabetes during COVID-19.
- New preliminary data from the T1D Exchange suggest that although hyperglycemia and diabetic ketoacidosis (DKA) are common in people with type 1 diabetes who develop COVID-19, many are still able to manage the illness at home and overall mortality is relatively low. Click here to read more insights into how half of those with COVID-19 and Type 1 diabetes manage the virus at home.
- New Global Registry Investigates COVID-19 and New-Onset Diabetes. There have been very initial observations on a possible tie between COVID-19 and the onset of diabetes.
Here are a few of the most exciting and important resources that we’ve seen about this topic in the last few weeks — we’ll be updating the list regularly as time goes on!
T1D Exchange is pleased to announce the preliminary results of its population health surveillance study, “Type 1 Diabetes and COVID-19: Preliminary Findings from a Multi-Center Surveillance Study in the United States,” recently published in Diabetes Care, the peer-reviewed medical journal of the American Diabetes Association.
The study focuses on individuals with type 1 diabetes (T1D) who are suspected or confirmed to have contracted Coronavirus Disease 2019 (COVID-19). This is the first U.S. based, multi-center study to examine patient characteristics and adverse outcomes among individuals with confirmed or suspected COVID-19.
- SUMMER IS HERE: ARE YOU STILL SAFER AT HOME? Read this piece on Weighing risks of exposure and how we can make smart choices.
- Check out this image on Instagram, shared to remind people to consider #BigLittleChanges.
- Click at the link to find on Facebook this video resource on how to cope with T1D during stressful and uncertain times.
- Watch this video about Navigating the Psychosocial Impacts of T1D on Children During Quarantine.
The American Diabetes Association (ADA)
- The COVID-19 Testing, Reaching and Contacting Everyone (TRACE) Act helps local organizations create mobile testing units and conduct door-to-door outreach with a special preference for hot spots and underserved communities.
- The Affordable Insulin for the COVID-19 Emergency Act would eliminate insulin cost-sharing for seniors living with diabetes enrolled in Medicare Part D during the COVID-19 emergency. Seniors would also be able to obtain a 90-day supply of insulin by mail to avoid the risk of going to the pharmacy.